Stay updated on RAS and Coagulopathy in COVID19 Clinical Trial
Sign up to get notified when there's something new on the RAS and Coagulopathy in COVID19 Clinical Trial page.

Latest updates to the RAS and Coagulopathy in COVID19 Clinical Trial page
- Check3 days agoChange DetectedA 403 Forbidden error message is now shown, along with basic site chrome, instead of the study record content and related documents. This makes the study information currently inaccessible to users.SummaryDifference19%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page footer shows an updated revision tag from v3.6.5 to v3.6.6, signaling a system/template update without modifications to the study details.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page now shows an error/unavailable message instead of the study record for the NCT04419610 entry, preventing access to the study details until the issue is resolved.SummaryDifference18%

- Check60 days agoChange DetectedThe page revision label at the bottom updated from v3.6.3 to v3.6.4, indicating a newer version of the page. This update pertains to metadata and page structure rather than substantive content changes.SummaryDifference0.1%

- Check81 days agoChange DetectedFooter revision label updated from v3.6.2 to v3.6.3, indicating a minor site/template version update rather than changes to the study content.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page's Revision tag has been updated to v3.6.2, replacing the previous v3.6.0 tag.SummaryDifference0.1%

Stay in the know with updates to RAS and Coagulopathy in COVID19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RAS and Coagulopathy in COVID19 Clinical Trial page.